4860 studies found for:
"Acquired Immunodeficiency Syndrome"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Yoga for the Management of HIV-Metabolic Syndromes
|
||||
| 2 | Completed |
A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers
|
||||
| 3 |
Completed
Has Results |
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
|
||||
| 4 |
Completed
Has Results |
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
|
||||
| 5 | Recruiting |
Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
|
||||
| 6 | Completed |
Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers
|
||||
| 7 | Recruiting |
Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV
|
||||
| 8 | Active, not recruiting |
A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
|
||||
| 9 | Completed |
TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients
|
||||
| 10 | Active, not recruiting |
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
|
||||
| 11 | Active, not recruiting |
A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
|
||||
| 12 | Unknown † |
HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
|
||||
| 13 | Completed |
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
|
||||
| 14 | Not yet recruiting |
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV
|
||||
| 15 | Not yet recruiting |
A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
|
||||
| 16 | Completed |
Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers
|
||||
| 17 | Completed |
Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection
|
||||
| 18 | Withdrawn |
Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women
|
||||
| 19 | Not yet recruiting |
Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents
|
||||
| 20 | Completed |
Twins Study of Gene Therapy for HIV Infection
|
† Indicates status has not been verified in more than two years
